REFRACTORY RHABDOID TUMOR OF THE KIDNEY

Clinical trials for REFRACTORY RHABDOID TUMOR OF THE KIDNEY explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY RHABDOID TUMOR OF THE KIDNEY trials appear

Sign up with your email to follow new studies for REFRACTORY RHABDOID TUMOR OF THE KIDNEY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for kids with tough cancers: trial targets a key genetic driver

Disease control Ongoing

This study is testing a drug called tipifarnib in children and young adults whose advanced cancers have a specific genetic change in a gene called HRAS. The goal is to see if the drug can shrink tumors and control the disease. Participants take the drug as a pill or through a fee…

Matched conditions: REFRACTORY RHABDOID TUMOR OF THE KIDNEY

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

REFRACTORY RHABDOID TUMOR OF THE KIDNEY

Get alerted when new REFRACTORY RHABDOID TUMOR OF THE KIDNEY trials appear

New hope for kids with tough cancers: trial targets a key genetic driver